SynthesisJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Overall response rate, progression-free survival, and overall survival with targeted and standard therapies in advanced non-small-cell lung cancer: US Food and Drug Administration trial-level and patient-level analyses.

Gideon M Blumenthal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.